Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

U.S. Market for Orthopedic Biomaterials 2010 (Executive Summary)

iData Research, April 2010, Pages: 10


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

In 2009, the orthopedic biomaterials market was valued at almost $3.5 billion. The total orthopedic biomaterials market has experienced growth, despite the economic downturn, which began in 2008. The market started to spike in 2009 and peaked in 2010 largely driven by rapid growth in the stem cell, hyaluronic acid and synthetic bone graft substitute market segments.

This comprehensive report critically examines the following market segments:

- Bone graft substitutes
- Cartilage repair
- Growth factors
- Hyaluronic acid
- Machined allografts
- Resorbable fixation
- Stem cells
- Tendon grafts
- Platelet rich plasma
- Bone marrow concentration systems

Within the U.S. orthopedic biomaterials market, companies such as Arthrex, DePuy, Genzyme, Medtronic, Synthes and Smith & Nephew lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Keywords:
bone graft substitutes, growth factors, machined allografts, hyaluronic acid viscosupplementation, resorbable fixation devices, tendon grafts, cartilage repair, platelet and bone marrow concentration, orthopedic stem cells and emerging technolgies



Customers who bought this item also bought

U.S. Markets for Orthopedic Biomaterials 2008

U.S. Markets for Orthopedic Biomaterials 2008 (Executive Summary)

Asia Pacific Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic Acid Viscosupplementation (Executive Summary)

Cell Therapy - Technologies, Markets and Companies

The Global Market for Orthobiological Products

Asia Pacific Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic Acid Viscosupplementation

Brazil Biomaterial Market (2010 – 2015)

Global Biomaterial Market (2010 - 2015)

Asia Pacific Markets for Orthopedic Biomaterials 2009 (Executive Summary)

Asia Pacific Markets for Orthopedic Biomaterials 2009



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds